Decision tools for atrial fibrillation; Driving and diabetes; Leukotriene receptor antagonists for viral wheeze; New NICE guidance; Managed Entry decisions
Needles for self-administering insulin using pens ; Fexofenadine: not the NI Formulary choice; Review: calcium & ergocalciferol tablets; New NICE guidance; Managed Entry decisions
In press: NICE guideline on antimicrobial stewardship; Reminder: tramadol not on repeat; Review: nebivolol 2.5mg tablets; New NICE guidance; Managed Entry decisions
NICE: ‘No change in practice’ following ezetimibe’s IMPROVE-IT study; NI Formulary: User survey invitation; Five reasons to avoid long-term PPIs; New NICE guidance; Managed Entry decisions
Denosumab — prescribe by brand; Flucloxacillin and hepatic disorders; SGLT2 inhibitors: risk of diabetic ketoacidosis; IV Medusa guide removed; New NICE guidance; Managed Entry decisions
Generic fluticasone / salmeterol MDIs available; Mirabegron (Betmiga®) not first line; A useful new resource: PrescQIPP; PDE5Is: not solely for lower urinary tract disorders; Managed Entry decisions
